Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Vesico-Ureteral Reflux | 2 | 2018 | 17 | 0.89 | Why? |
Urinary Tract | 2 | 2019 | 77 | 0.71 | Why? |
Dapsone | 1 | 2017 | 59 | 0.67 | Why? |
Adrenal Insufficiency | 1 | 2018 | 190 | 0.60 | Why? |
Antiphospholipid Syndrome | 1 | 2018 | 533 | 0.47 | Why? |
Autoimmunity | 2 | 2019 | 841 | 0.43 | Why? |
Neutrophils | 4 | 2017 | 5476 | 0.37 | Why? |
Extracellular Traps | 1 | 2017 | 1036 | 0.36 | Why? |
Lupus Erythematosus, Systemic | 1 | 2018 | 1380 | 0.33 | Why? |
Autoimmune Diseases | 2 | 2019 | 1996 | 0.33 | Why? |
Urinary Tract Infections | 2 | 2018 | 534 | 0.22 | Why? |
Hypoventilation | 1 | 2018 | 17 | 0.19 | Why? |
Nephritis | 1 | 2019 | 39 | 0.19 | Why? |
Renal Nutcracker Syndrome | 1 | 2017 | 3 | 0.18 | Why? |
Hypothalamus | 1 | 2018 | 58 | 0.18 | Why? |
Maintenance Chemotherapy | 1 | 2019 | 133 | 0.18 | Why? |
Renal Veins | 1 | 2017 | 13 | 0.18 | Why? |
Attention | 1 | 2021 | 335 | 0.18 | Why? |
Maternal Age | 1 | 2019 | 244 | 0.18 | Why? |
Induction Chemotherapy | 1 | 2019 | 149 | 0.18 | Why? |
Glomerulosclerosis, Focal Segmental | 1 | 2019 | 104 | 0.18 | Why? |
Autonomic Nervous System Diseases | 1 | 2018 | 67 | 0.18 | Why? |
Chemotaxis | 1 | 2017 | 67 | 0.17 | Why? |
Free Radicals | 1 | 2017 | 55 | 0.17 | Why? |
Pyelonephritis | 1 | 2018 | 66 | 0.17 | Why? |
Kidney Glomerulus | 1 | 2019 | 144 | 0.17 | Why? |
Peroxidase | 1 | 2017 | 207 | 0.16 | Why? |
Receptors, Urokinase Plasminogen Activator | 1 | 2019 | 252 | 0.16 | Why? |
Capillary Leak Syndrome | 1 | 2017 | 119 | 0.15 | Why? |
Hematuria | 1 | 2017 | 284 | 0.15 | Why? |
Human Umbilical Vein Endothelial Cells | 1 | 2017 | 286 | 0.15 | Why? |
Congenital Abnormalities | 1 | 2017 | 170 | 0.15 | Why? |
Neuroendocrine Tumors | 1 | 2018 | 241 | 0.15 | Why? |
Prenatal Exposure Delayed Effects | 1 | 2019 | 319 | 0.14 | Why? |
Genetic Association Studies | 1 | 2017 | 559 | 0.14 | Why? |
Hyponatremia | 1 | 2018 | 371 | 0.14 | Why? |
Vasculitis | 2 | 2019 | 691 | 0.13 | Why? |
Antidepressive Agents | 1 | 2019 | 509 | 0.13 | Why? |
Search Engine | 1 | 2021 | 628 | 0.13 | Why? |
Inflammasomes | 1 | 2019 | 710 | 0.12 | Why? |
Hydrogen Peroxide | 1 | 2017 | 680 | 0.12 | Why? |
Interleukin-8 | 1 | 2017 | 964 | 0.11 | Why? |
Autism Spectrum Disorder | 1 | 2019 | 587 | 0.11 | Why? |
Leukocytes | 1 | 2017 | 1046 | 0.10 | Why? |
Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.10 | Why? |
Biomarkers | 5 | 2019 | 23361 | 0.09 | Why? |
Pregnancy Complications | 1 | 2019 | 1388 | 0.09 | Why? |
Cytokines | 2 | 2021 | 15010 | 0.08 | Why? |
Macrophages | 1 | 2019 | 2784 | 0.08 | Why? |
Immunoglobulin A | 1 | 2017 | 3567 | 0.07 | Why? |
Blood Sedimentation | 2 | 2018 | 508 | 0.07 | Why? |
Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.07 | Why? |
Prognosis | 5 | 2019 | 32490 | 0.07 | Why? |
Clinical Trials as Topic | 2 | 2021 | 7330 | 0.07 | Why? |
Humans | 29 | 2021 | 930598 | 0.07 | Why? |
Oxygen | 1 | 2017 | 3715 | 0.06 | Why? |
Rheumatic Diseases | 1 | 2019 | 2675 | 0.06 | Why? |
Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
Kidney Failure, Chronic | 1 | 2019 | 3222 | 0.06 | Why? |
Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
Inflammatory Bowel Diseases | 1 | 2019 | 3209 | 0.06 | Why? |
Multiple Sclerosis | 1 | 2017 | 2600 | 0.06 | Why? |
Sambucus | 1 | 2020 | 17 | 0.05 | Why? |
Chills | 1 | 2020 | 102 | 0.05 | Why? |
Area Under Curve | 2 | 2018 | 2564 | 0.05 | Why? |
STAT Transcription Factors | 1 | 2021 | 173 | 0.05 | Why? |
Inflammation | 2 | 2020 | 13255 | 0.05 | Why? |
Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.05 | Why? |
Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
Fever | 1 | 2017 | 7795 | 0.05 | Why? |
Coronavirus Infections | 7 | 2021 | 253789 | 0.05 | Why? |
Social Media | 1 | 2021 | 5798 | 0.05 | Why? |
Leukocyte Count | 2 | 2020 | 3178 | 0.05 | Why? |
Valine | 1 | 2021 | 359 | 0.05 | Why? |
DNA Copy Number Variations | 1 | 2018 | 84 | 0.05 | Why? |
Nasal Sprays | 1 | 2020 | 234 | 0.04 | Why? |
Succimer | 1 | 2017 | 4 | 0.04 | Why? |
Republic of Korea | 2 | 2021 | 5858 | 0.04 | Why? |
Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
Reflex | 1 | 2017 | 22 | 0.04 | Why? |
Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
C-Reactive Protein | 3 | 2020 | 7972 | 0.04 | Why? |
Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
Child | 4 | 2020 | 70012 | 0.04 | Why? |
Exome | 1 | 2018 | 207 | 0.04 | Why? |
Janus Kinases | 1 | 2021 | 414 | 0.04 | Why? |
Carbamates | 1 | 2021 | 485 | 0.04 | Why? |
Povidone-Iodine | 1 | 2020 | 213 | 0.04 | Why? |
Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.04 | Why? |
Constriction, Pathologic | 1 | 2017 | 212 | 0.04 | Why? |
Epidemiologic Methods | 1 | 2020 | 392 | 0.04 | Why? |
Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
Pyrrolidines | 1 | 2021 | 558 | 0.04 | Why? |
Plant Preparations | 1 | 2020 | 276 | 0.04 | Why? |
Sofosbuvir | 1 | 2021 | 518 | 0.04 | Why? |
Glomerulonephritis | 1 | 2019 | 226 | 0.04 | Why? |
Mouthwashes | 1 | 2020 | 432 | 0.04 | Why? |
Causality | 1 | 2019 | 857 | 0.04 | Why? |
Pandemics | 10 | 2021 | 389249 | 0.04 | Why? |
Imidazoles | 1 | 2021 | 631 | 0.04 | Why? |
Remission Induction | 1 | 2019 | 950 | 0.04 | Why? |
ROC Curve | 2 | 2018 | 6024 | 0.04 | Why? |
Purines | 1 | 2021 | 816 | 0.04 | Why? |
Azetidines | 1 | 2021 | 722 | 0.03 | Why? |
Lung | 2 | 2020 | 31049 | 0.03 | Why? |
Steroids | 1 | 2020 | 904 | 0.03 | Why? |
Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
Morbidity | 1 | 2020 | 1426 | 0.03 | Why? |
Syndrome | 1 | 2018 | 1310 | 0.03 | Why? |
Signal Transduction | 2 | 2021 | 7207 | 0.03 | Why? |
Environment | 1 | 2019 | 769 | 0.03 | Why? |
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.03 | Why? |
Gene Regulatory Networks | 1 | 2017 | 820 | 0.03 | Why? |
Female | 8 | 2020 | 380317 | 0.03 | Why? |
Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
Sulfonamides | 1 | 2021 | 1294 | 0.03 | Why? |
Smoking Cessation | 1 | 2020 | 826 | 0.03 | Why? |
Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.03 | Why? |
Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
Probiotics | 1 | 2019 | 694 | 0.03 | Why? |
Male | 7 | 2020 | 367725 | 0.03 | Why? |
Child, Preschool | 3 | 2020 | 36283 | 0.03 | Why? |
Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
Infant | 3 | 2018 | 30274 | 0.03 | Why? |
Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
Polymorphism, Genetic | 1 | 2017 | 1074 | 0.03 | Why? |
Pyrazoles | 1 | 2021 | 1791 | 0.03 | Why? |
Animals | 4 | 2021 | 78931 | 0.02 | Why? |
Crohn Disease | 1 | 2019 | 959 | 0.02 | Why? |
Biopsy | 1 | 2019 | 2811 | 0.02 | Why? |
Colitis, Ulcerative | 1 | 2019 | 1037 | 0.02 | Why? |
Precision Medicine | 1 | 2019 | 1477 | 0.02 | Why? |
Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.02 | Why? |
Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
Genomics | 1 | 2020 | 3118 | 0.02 | Why? |
Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
Young Adult | 1 | 2018 | 93724 | 0.02 | Why? |
Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
Adaptive Immunity | 1 | 2019 | 2585 | 0.02 | Why? |
Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
Cough | 1 | 2020 | 4891 | 0.02 | Why? |
Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
Public Health | 2 | 2021 | 16359 | 0.02 | Why? |
Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
Adult | 2 | 2019 | 244371 | 0.02 | Why? |
China | 2 | 2021 | 50654 | 0.02 | Why? |
Middle Aged | 2 | 2019 | 270681 | 0.02 | Why? |
Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
Disease Outbreaks | 2 | 2021 | 27595 | 0.02 | Why? |
Retrospective Studies | 3 | 2019 | 105322 | 0.01 | Why? |
Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
Aged | 1 | 2018 | 215776 | 0.01 | Why? |
Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
Immunity, Innate | 1 | 2019 | 6570 | 0.01 | Why? |
United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
Pregnancy | 1 | 2019 | 23879 | 0.01 | Why? |
Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
Italy | 1 | 2021 | 38444 | 0.01 | Why? |
Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
United States | 1 | 2021 | 46150 | 0.01 | Why? |
Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_